day 1 agenda

Day 1 (June 29, 2026)
Registrations Open
Opening Ceremony
KEYNOTE TALKS
 
09:30-10:00 Title: Impact of body mass index on the surgical outcomes and delayed adjuvant treatment in patients undergoing therapeutic mammoplasty for breast cancer
Maged Hussien, Norfolk and Norwich University hospital, United Kingdom
   
10:00-10:30 Title: Medical research ethics with a focus on breast cancer
Jukka H. Meurman, University of Helsinki, Finland
   
10:00-10:30 Title: Translational Bioinformatics Resources and AI Solutions for Cancer Research
Trupti Joshi, Marshall University, USA
   
 Group Photo
10:30-10:45 ---Refreshment Break @ Foyer  
   
Plenary Talk
10:45-11:10 Title: A novel HER2 protein identification methodology in breast cancer cells using Raman spectroscopy and raman imaging: an analytical validation study
Halina Abramczyk, Lodz University of Technology, Poland
   
11:10-11:30 Title: Fraction B Preparation from Catfish Skin is a Good Candidate for treating Breast Cancer Without the Use of Surgery, Radiation or Chemo Treatment and for Healing Wounds Cosmetically After Breast Cancer Surgery
  Jassim M. H. AlMohammad Ali, Abdullah AlSalem University, Kuwait
   
SPEAKER PRESENTATIONS
   
11:30-11:50 Title: Identification and Therapeutic Targeting of Tumor-initiating Cells in Triple-negative Breast Cancer (TNBC)
Michael T. Lewis, Baylor College of Medicine, USA
   
11:50-12:10 Title: Shaping the Future: AI-Driven Solutions in Breast Reconstruction
Edward Ray,Cedars-Sinai Medical Center, USA
   
12:10-12:30 Speaker SlotsAavailable
   
12:30-12:50 Title: PTEN inactivating mutations are associated with hormone receptor loss during breast cancer recurrence
Haiying Zhan, Yale University, USA
  Networking & Panel Discussion
12:50-13:50  Lunch Break @ Restaurant 
   
13:50-14:10 Title: Dissecting Notch-driven EMT programs at single-cell resolution in breast cancer
Magdalena Orzechowska, Medical University of Lodz, Poland
   
14:10-14:30 Title: Mechanisms of Action of FDA-Approved Endocrine Therapies for ER-Positive Breast Cancer
Kiven Erique Lukong, University of Saskatchewan, Canada
   
14:30-14:50 Title: DCIS-associated myoepithelial cells create a pro-tumorigenic microenvironment through up-regulation of integrin αvβ6
J Louise Jones, Queen Mary University of London, UK
   
14:50-15:10 Speaker SlotsAavailable
   
15:10-15:30 Title:Proteomics Approaches in Discovery of Potential Enzymatic Biomarkers for Early Diagnosis of Breast Cancer
Zoran Minic, University of Ottawa, Canada
   
15:30-15:50 Speaker SlotsAavailable
   
15:50-16:10 Title: Targeting Tumor-Associated Hydroxyapatite to Disrupt Tumor Metabolism: A Novel Therapeutic Strategy for Breast Cancer Using Nanodrugs
Mohammed Noor Tantawy, Vanderbilt University Medical Center, USA
16:10-16:20 Refreshment Break
16:20-16:40 Speaker SlotsAavailable
   
16:40-17:00 Title: Natural looking breast after primary reconstruction using inferior dermal flap as internal bra and submuscular silicone implant
Jasmina Gjorgievska Pavlovska, University Clinic of Plastic and reconstructive surgery - North Macedonia
   
17:00-17:20 Title: Natural looking breast after primary reconstruction using inferior dermal flap as internal bra and submuscular silicone implant
Sanchita Bhatnagar, University of California Davis, USA
  Networking & Panel Discussion
Day-1 Concludes

day 2 agenda

Day 2 (June 30th, 2026)
KEYNOTE TALKS
09:30-10:00 Title: Breast Cancer Diagnosis using Subtraction of Temporally Sequential Digital Mammograms
Kosmia Loizidou, University of Cyprus, Cyprus
   
10:00-10:30 Keynote Speaker soty available
   
10:30-11:00 Keynote Speaker soty available
11:00-11:15 ---Refreshment Break @ Foyer  
SPEAKER PRESENTATIONS
   
11:15-11:35 Title: Growth inhibitory effect of Leptospermum scoparium (manuka) chloroform extract on breast and liver cancer cell lines
Mohammed Musa Yahya Alzahrani, Imam Mohammad Bin Saud Islamic University, Saudi Arabia
   
11:35-11:55 Title: Systems-Level Reprogramming of Breast Cancer by the Traditional Chinese Medicine Formula T33: Integrating Epigenetic Regulation, Autophagy, and Tumor Evolution
YuTe Liu, Chung Shan Medical University, Taiwan
   
11:55-12:15 Speaker SlotsAavailable
   
12:15-12:35 Speaker SlotsAavailable
   
12:35-12:55 Title: CHA1: An Epigenetics-Plus Combinatorial Therapy That Enables Immune Checkpoint Susceptibility with Epigenetic Disruption
Amy S Yee, Tufts University School of Medicine, New Orleans (LSUHSC-NO), USA
  Networking & Panel Discussion
12:55-13:55  Lunch Break @ Restaurant 
13:55-14:15 Title: A New Era in Breast Reconstruction: Deepithelialized Axio-perforator, Bipedicled (MDG AP) Flap for Immediate Combined Breast/NAC Reconstruction
Vagif Kalender (Galandarov), Azerbaijan Medical University, Azerbaijan
   
14:15-14:35 Title: Crosstalk Between Metabolism and Translation in Highly Metastatic Triple-Negative Breast Cancer (TNBC)
Columba De La Parra, Lehman College- City University of New York, USA
   
14:35-14:55 Title: TBA
Hanna Romanska-Knight, Medical University of Lodz, Poland
   
14:55-15:15 Speaker SlotsAavailable
   
15:15-15:35 Title: Association of Oxidative DNA Damage Marker 8-Hydroxydeoxyguanosine with Immunological and Tumor Characteristics in Breast Cancer
Yahia Saddek, Ahmed Ben Bella Oran 1 University, Algeria
   
15:35-15:55 Title: Breast cancer diagnosis at age 85 and older
Jacqueline Tsai, Stanford University, USA
   
15:55-16:15 Speaker SlotsAavailable
16:15-16:30 Refreshment Break
16:30-16:50 Title: Human Diversity in Breast Cancer Microphysiological Models
Cecilia Sanchez, Obatala Sciences Inc, USA
   
16:50-17:10 Speaker SlotsAavailable
   
17:10-17:30 Speaker SlotsAavailable
   
17:30-17:50 Speaker SlotsAavailable
   
  Networking & Panel Discussion
Closing Ceremony
Please note that program is tentative, and the timings are subject to change
If any one interested to attend the conference or to book your speaker slot, please send an email to breastcancer@innovinc.org 

Virtual agenda

Day 2 (June 30, 2026)-Virtual Presentations

Time Zone: Central European Time (CET)
11:20-11:40 Title: Association between adjuvant chemotherapy and outcomes after resection of locoregional recurrence in hormone receptor–positive HER2-negative breast cancer: a multi-institutional retrospective study
Yukinori Ozaki, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Japan
   
11:40-12:00 Title: Real time App Deployment : Analysis of Image for Breast Cancer Detection using Feature-Rich Deep Learning Architecture
Pinki Roy, National Institute of Technology Silchar, India
   
12:00-12:20 Title: Mutation analysis in investigating the status of genes associated with homologous recombinant repair in hormone receptor-positive breast cancer
Tekincan Cagr? Aktas, Ege University Faculty of Medicine, Turkey
   
12:20-12:40 Speaker SlotsAavailable
   
12:40-13:00 Speaker SlotsAavailable
   
13:00-13:20 Title: Immunomodulating and antiproliferative effects of novel N-chalconyl im-idazolidones in breast cancer models
Atziri Corin Chavez Alvarez, Université Clermont-Auvergne, France
   
13:20-13:30 Title: Expression of PD-L1, IRF1 and CD8 T Lymphocyte Infiltration in a Primary Subset of Breast Cancer Patients in Sudan
Shahenaz Shaban Salih Mohamed Nour, Sudan University of Sciences and Technology, UAE
   
13:30-13:50 Title: HER2 amplification by next-generation sequencing to identify her2-positive invasive breast cancer with negative her2 immunohistochemistry
Ying S. Zou, The Johns Hopkins University, USA
   
13:50-14:10 Speaker SlotsAavailable
   
14:10-14:30 Title: Relationship between diagnostic characteristics, lifestyle habits and breast cancer subtypes in women
Fernanda Cristina Marin, Escola de Enfermagem da Universidade de São Paulo, Brazil
   
14:30-14:50 Title: The Prognostic Utility of Perioperative Blood-based Liquid Biopsy in Patients with Non-metastatic Breast Cancer
Fara Hassan, Cork University Hospital, Ireland
   
14:50-15:10 Title: The Causal Effect of 24-hour Activity Patterns in Adulthood on Breast Cancer Risk Among Polish Migrant Women in US
Azam Najaf Kouchak, Michigan State University, USA
   
15:10-15:30 Speaker SlotsAavailable
   
15:30-15:50 Title: A Case of Grade II Breast Mucinous Carcinoma Progression from Ductal Carcinoma in Situ
Clara Straus, St. John's Episcopal Hospital, USA
   
15:50-16:10 Title: Dose-Dependent Mitochondrial Reprogramming by Biguanides Antagonistically Regulates c-Src–Driven Tumor Progression
Benny Abraham Kaipparettu, Baylor College of Medicine, USA
   
16:10-16:30 Speaker SlotsAavailable
   
16:30-16:50 Title: Beyond Cancer: BRCA as Guardians of Cardiovascular Homeostasis
Krishna Singh, Western University, London
   
16:50-17:10 Title: Prospective study of emergency medicine provider wellness across ten academic and community hospitals during the initial surge of the COVID-19 pandemic
Kelker Heather, Riley Hospital for Children at Indiana Unversity Health, USA
   
17:10-17:30 Speaker SlotsAavailable
   
17:30-17:50 Title: Exercise as Medicine in Cardio-Oncology: Reducing Health Disparities in Hispanic and Latina Breast Cancer Survivors
Christina M. Dieli-Conwright, Harvard Medical School, USA
   
17:50-18:10 Title: The utility of PARP inhibitors as single-agents and in combination in breast cancer
Saima Hassan, University of Montreal, Canada
   
18:10-18:30 Title: Rare Breast Cancers Review
Harnoor Singh, University of Texas at Houston, USA
   
18:30-18:50 Speaker SlotsAavailable
   
18:50-19:10 Title: Estimating the Lifetime Risk of Breast Cancer With and Without a Screening History
Dongfeng Wu, University of Louisville, USA
   
19:10-19:30 Title: TBA
Sohail Tavazoie, The Rockefeller University, USA
   
19:30-19:50 Title: A novel method of finding non-infectious disease causes by combining multiple research and results of its application: A unique combination of physiological changes which causes Breast Cancer
Alan Olan, Independent Researcher, USA
   
19:50-20:10 Speaker SlotsAavailable
   
20:10-20:30 Speaker SlotsAavailable
   
20:30-20:50 Title: Molecular testing and targeting for solid tumors with CNS metastases
Toni Cao, Stanford University School of Medicine, USA
   
20:50-21:10 Speaker SlotsAavailable
   
21:10-21:30 Title: Recent progress on optical imaging for intraoperative assessment of tumor margins during lumpectomy
Bing Yu, Marquette University and Medical College of Wisconsin, USA
Closing Ceremany
Note: This is the tentative program only and the timings may be subject to change
If any one interested to attend the conference or to book your speaker slot, please send an email to   breastcancer@innovinc.org 

Download